Rayn KN, et al. - Researchers evaluated the additional value of preoperative prostate multiparametric magnetic resonance imaging (mpMRI) and transrectal ultrasound/mpMRI fusion-guided targeted biopsy (Tbx) when used in combination with clinical nomograms in predicting adverse pathology at radical prostatectomy. A significant additional predictive ability of adverse pathology at the time of RP was provided by MRI alone or in addition to standard clinical nomograms. For preoperative planning and when counseling patients regarding risks of future therapy, this information could be greatly beneficial to urologists.